Pharmaceutics & Advanced Drug Delivery Systems is on Mar 27 2023 at Paris

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme

Pharmaceutical Science's Most Recent Advances and Innovations.

- Pharmaceutical Science 2023

About Conference

Venue Information

Hyatt Place London Heathrow Airport

Address: The Grove, Bath Rd, Harmondsworth, West Drayton UB7 0DG, United Kingdom

Bus, taxi and town car available to the venue from Terminal 2 & 3.

The central bus station at Heathrow Airport, which is near to terminal 2, makes it simple to get to Hyatt Place, London Heathrow Airport.

You can get to the hotel by taking the free bus U3 from this location, which is 4 stops away. The bus rides should take 5 to 10 minutes, and they run frequently.

Looking forward to seeing you soon.

On March 27-28, 2023, the 7th International Conference on Pharmaceutics and Advanced Drug Delivery Systems will welcome you to London, UK. Pharmaceutical Science 2023 encompasses practically every aspect of knowledge, innovation, technology, and networking, with the goal of bringing academics, practitioners, and business executives together to debate the most pressing issues in pharma, biotech, and health care.

Drug Discovery and Development, Pharmacovigilance and Drug Safety, Novel Drug Delivery Systems and Drug Therapy, Pharmaceutical Nanotechnology, Drug Regulatory Affairs, Pharmacology, Neuropharmacology, Nutraceuticals, Pharma Marketing, and more are all covered in this two-day program.

Pharmaceutical Science 2023 provides unrivalled business, research, and market access prospects in the pharmaceutical and health-care industries. Be the first to learn about new and often unavailable information, and discover a field that interests you.

By participating in Pharmaceutical Science 2023, you will be able to see the rising industry and provide your career and business with new opportunities from all over the world.

WHO WILL ATTEND?

Biotechnology experts, researchers, and scientists
Professors and Students in Academia
Companies in the pharmaceutical and biotechnology industries
Departments of Healthcare
Practitioners & Pharmacists
Officials, decision-makers, and government heads
R&D Labs, Policymakers, and Influencers

WHY IS THE PHARMACEUTICAL SCIENCE IMPORTANT?

Meet the Pioneers in the Pharmaceutical and Healthcare Industries
Translational research and evidence-based approaches should be widely disseminated.
Investigate Future Business Prospects
Get the latest news from hard-to-reach academic and business specialists.
Distribute your goods and services
Rekindle your friendships with your co-workers.
Expect real-life examples and shared experience as a result of the case study.

Sessions and Tracks

Become a Presenter

Submit an Abstract

Start by submitting a proposal if you want to give a presentation.

The following information will be required: presentation type, short/long descriptions, keywords, focus, topics, and biographical information.

Get Approved

Following receipt of your presentation proposal, we will proceed to the evaluation stage. The Organizing Committee will assess all suggestions within 24 hours after their submission.

You must register before our Program Development staff can schedule your presentation once your abstract has been accepted.

Submit an Abstract

Session on Pharmacogenomics

Gene testing for drugs, Personalized medicine and pharmacogenomics Challenges, Current restrictions on drug labelling Drug Sensitivity and Genetics, Costs and coverage of pharmacogenomics testing Predicting drug-drug interactions is a difficult task. Polypharmacy, Methods based on associations and expressions, Pathway-based techniques and cheminformatics Incorporation of pharmacogenomics into clinical practise Phenotyping and genotyping are two terms that are used interchangeably.

Session on Neuropharmacology

Neurotransmission in the central and peripheral nervous systems, Neurotoxicology, Growth factors for the nerves, cytoskeletal elements of the nervous system, Repairing the brain, Addiction's cellular and molecular mechanisms, Disorders of development and Neurodegeneration interactions between the brain and the immune system.

Session on Pharmacology

Clinical pharmacology, such as cardiac pharmacology and cardiovascular disease, pulmonary disease, neurodegenerative disorders, pharmacological oncology, Parkinson's disease, and circadian rhythm disorders, Molecular and Cellular Pharmacology, such as drug-receptor interactions, drug-enzyme interactions, antibiotic pharmacology, and immune responses, gene expression regulation, Pharmacogenetics, Safety Pharmacology, Toxicology, and Pharmacognosy, Environmental Pharmacology

Session on Pharmaceutical Marketing, Big Data & Analytics

Pharmaceutical Formulations Market, Licensing, Pharma Pricing & Market Access, Global Generic Trends & Global Pharma Market, Global Generic Trends & Global Pharma Market, Global Generic Trends & Global Pharma Market, Global Generic Trends & Global Pharma Market, Global Generic E-pharmaceutical marketing, post-market surveillance, the generic drug industry, contract manufacturing, and health economics, to name a few. Customer Lifetime Valuation, Patient-Centricity, Pharma Segmentation/Localization, Predictive Analytics, Pre-clinical Discovery, Commercial Models, Customer Lifetime Valuation, Patient-Centricity Statistical Approaches for Improving Performance and Compliance with Big Data, Architecture, Informatics, and Big Data.

Session on Digital Pharma & Multichannel Marketing

Data-Driven Health and Personalization, the Role of Artificial Intelligence in the Pharmaceutical Industry, Digital transformation on a global scale, calculating digital ROI, and analyzing digital analytics. It is critical to align innovation with company objectives. Customer Digital Habits, Channel Preferences, New Levels of Targeting, Investment Allocation, A True Learning Plan's Metrics, Marketing in a Multichannel World, Multichannel Engagement Mobilizing for Mobile Engagement, Customer Digital Habits, Channel Preferences, New Levels of Targeting, Investment Allocation, A True Learning Plan's Metrics

Session on Pharmaceutical Microbiology & Emerging Biotechnology

Pharmaceutical microbiology and animal biotechnology have evolved as a useful field for the productions of biologics from microbial cells or animal or human cell lines. Biotechnological concepts and manipulations in the these filed has enhanced the production, variety and types of biologics produced. These field are expected to grow further in the future.

Session on Pharmaceutical Chemistry & Medicinal Chemistry

Pharmaceutical and medical chemistry are interdisciplinary scientific topics that deal with drug development, molecular mechanisms of pathogenesis, pharmaceutics, pharmacology, toxicology, organic chemistry, and more. Individual investigations in both disciplines provide improved insights and understanding for the creation of novel medications and therapies.

Session on Biopharmaceutical

In the field of pharmaceutical biotechnology, recent developments have been made. Recombinant DNA Technology: Basic Techniques and Tools, Vectors, Cloning Strategies, and Host Systems Genetic engineering has been used to make recombinant therapeutic proteins, vaccines, recombinant blood products and therapeutic enzymes, as well as nucleic acid and cell-based medicines.

Session on Pharmaceutical Nanotechnology

Pharmaceutical nanotechnology provides innovative tools and technology, as well as opportunities and scope, in many areas of the healthcare industry, and it is now well-established as a specialized area for drug delivery, diagnostics, prognostics, and various treatment procedures, thanks to its Nano-engineered tools and techniques. By overcoming the constraints of present technology in the pharmaceutical sector, it will have a significant impact in the future.

Session on Pharmacovigilance & Drug Safety

In the field of drug regulation, pharmacovigilance is a term that is used to describe the monitoring of Trials in Medicine, Clinical safety prior to marketing, Safety of drugs once they've been released, Strategies for risk management, Data mining and signal detection Drug interaction detection, Harmonization of drug regulatory requirements on a global scale, Management of risks and crises Traditional and Herbal Medicines, Vaccines and biological medicines are two examples of vaccines.

Session on Drug Discovery & Development

Drug discovery and development in its entirety, encompassing genomics and proteomics research, applications, technologies, and tactics to speed up the pace and productivity of drug development. Pharmacotherapy, Clinical trials, Case studies in a variety of therapeutic and disease domains, translational medicine, translational and preclinical models

Session on Clinical Trials & Drug Regulatory Affairs

Recent advancements in research, Clinical trials, patient-centered clinical trial techniques, Preclinical Research Innovations, Medical Imaging, Clinical Trial Participation Multi-arm multi-stage (MAMS) trials, Pharmacodynamics, Screening, Ethical aspects, Patient safety, International Regulatory Affairs, Quality assurance, Biosimilars Licensing and authorization are required. Regulatory Affairs, Regulatory and Post-Marketing Issues: International Guidelines

Session on Challenges in Drug Delivery

This session addresses important issues in drug delivery systems such as poorly soluble drug component distribution and bioavailability, as well as drug molecules' inaccessibility to the target location. Biologics (peptides, proteins, and DNA-based therapies) drug delivery, as well as pediatric and geriatric medication delivery, are all major challenges. Despite the fact that various tactics and procedures have been created to address drug delivery issues, they have some flaws. Such barriers in drug delivery systems can be overcome with the help of innovative technology.

Sessions on Advances in Drug Delivery

Session on Nanotechnology & Drug Carrier Systems

Nanotechnology, polymer science, and biomaterial sciences all have a lot of potential and opportunity for developing innovative medication delivery techniques and systems.

Session on Novel Drug Delivery System

Recent therapeutic application and formulation system development efforts to boost medication delivery potential, Drug Delivery Carrier, Nanoparticles, Mucoadhesive Drug Delivery System, Novel Drug Delivery System and Market Opportunities, Drug Delivery Biomaterials, Routes of Administration, Future Opportunities and Challenges, Drug Therapy

Session on Alternative Drug Delivery System

The most often utilized drug delivery systems are the oral and parenteral drug administration systems. Alternative drug delivery mechanisms such as pulmonary drug delivery, transdermal drug delivery, prodrug delivery, ocular drug delivery, and transmucosal drug delivery will be discussed in this session.

Session on Peptides & Protein Drug Delivery

The obstacles of delivering protein-based treatments have grown dramatically since the development of peptide and protein medicines. This session will cover issues in various types and routes of peptide and protein drug delivery, vaccine design and drug delivery, recent advances in protein-based drug delivery, and solutions to overcome drug delivery-related constraints.

Session on Nutraceuticals

Disease Prevention and Treatment using Nutraceuticals, Probiotics and Prebiotics, Nutraceuticals for Weight Management, Dietary Supplements & Functional Foods, Personalized Nutrition and Medicine Probiotics and prebiotics, Skincare Supplements and Cosmetics, Nutraceuticals Markets-Growth Trends, Nutraceuticals Markets-Growth Trends, Nutraceuticals Markets-Growth Trends, Nutraceuticals Markets-Growth Trends, Nutraceuticals Markets-Growth Trends.

Session on Cosmeceuticals

Cosmetics' Function, Cosmetics' biological impacts, a framework for regulation How do cosmetics vary from pharmaceuticals? Product Evaluation, Cosmetics and Microbiological Safety, Hair and Skin Care, Packaging, efficacy and safety Processes for anti-aging and tissue repair Biotech product development opportunities and challenges Cosmetics and the marketplace, the interface and interaction between food and cosmetics, Animal Experiments, Microbeads made of plastic, Endocrine disruptors, endocrine disruptors, endocrine disruptor Products that are fakes

Market Analysis

WORLD WIDE PHARMA MARKET

Globally, the pharmaceutical 2023 spent over 238 billion dollars on research and development in 2021. In 2012, R&D spending reached a total of 137 billion dollars. Pharmaceutical R&D covers all phases of clinical trial development, including pre-clinical chemical testing and basic disease process research. A governmental authority gets engaged at a given point in the procedure, typically during the pre-clinical stage, to review, oversee, and finally approve the drug. The Food and Drug Administration is the main organization in charge of procedures in the US.

Significant advancements in pharmaceutical research and development have started to alter the R&D environment during the last few years. With the primary goal of cutting costs, an increasing number of pharmaceutical companies are contracting out a sizable portion of their R&D to clinical research organizations, often known as contract research organizations. The application of big data to clinical research is another significant advance. Thus, it is conceivable to create a prediction model that integrates clinical and molecular data to create medications that are both safer and more effective. Real-time or real-world evidence (RWE) in particular is gaining more and more attention. This necessitates working with technology businesses and incorporates information obtained from a variety of sources, including social media.

An industry leader in company, market, and consumer research is The Business Research Company. It has specialists in a variety of areas, including manufacturing, healthcare, financial services, chemicals, and technology, and it is located all over the world.

The flagship product of The Business Research Company, Global Market Model, is a market intelligence platform that offers a wide range of macroeconomic measures and indicators for 60 different geographic areas and 27 different industries. The Global Market Model includes multi-layered statistics that assist in determining supply-demand gaps for its consumers.

EUROPE PHARMACEUTICAL MARKET

The pharmaceutical market in Europe was estimated to be worth USD 282.75 billion in 2020, and it is anticipated to increase at a CAGR of 5.4% from 2021 to 2028. The rise of biologics and biosimilars, rising R&D spending, and rising healthcare costs can all be blamed for the growth. Additionally, a favorable regulatory environment and reimbursement policies increase the uptake of pharmaceuticals in this region, promoting market expansion. The COVID-19 has had a mixed effect on the sector. Due to the decline in disease diagnostic rates, including cancer, it has had a negative impact on the rate of medicine prescription and uptake. For instance, a drop-in primary care drug prescriptions in 2020 was responsible for a decline in the use of biologics and new medicines. The lack of pharmaceuticals as a result of supply chain interruptions exacerbates the fall in drug sales.

PHARMACEUTICAL MARKET IN THE UNITED KINGDOM (UK)

Pharmaceutical wholesalers in the UK generated more than 51 billion British pounds in revenue in 2019. The pharmaceutical market in the United Kingdom, which accounts for about 2.5% of worldwide pharmaceutical sales, is one of the top 10 national markets in the world. In the UK, there were nearly 670 companies producing pharmaceutical goods and preparations in 2019. Research and development as a proportion of sales in pharmaceutical manufacturing was worth about 40% because innovation is a significant component and requirement of the pharmaceutical business. With approximately 50,000 people employed in the manufacturing and preparation of pharmaceuticals alone, the pharmaceutical industry also makes a significant contribution to the economy.

Pharmaceutical imports from the rest of the European Union totaled about 21 billion US dollars in 2020 for the United Kingdom. When compared to the years prior to the Brexit, when imports were as high as 26 billion dollars, this is a considerable drop. The COVID-19 pandemic's effects, however, could also be to blame for this development.

In a 2018 study of EU influencers, 32% of respondents said Brexit would severely affect EU pharmaceutical industries, while 41% thought trade obstacles might have an effect on the availability of medicines. Another study of board-level executives in the pharmaceutical industry also found that 50% of respondents said Brexit had a negative impact on the appeal of the UK pharmaceutical market.

What can the global community learn from the UK’s pharmaceutical industry?

2020 is continuing to deliver swift and unexpected changes to our way of life as the year goes on. The way we work may have changed, and basic questions about the proper operation of economies are being challenged. The UK pharmaceutical sector, despite this turmoil, has persevered and produced under extremely difficult conditions. Pharma has demonstrated outstanding inventiveness and teamwork at a time when it is most required, even amongst the confusion of COVID-19.

The National Health Service (NHS) of the United Kingdom (UK) is a significant player in the larger pharmaceutical supply chain.

The National Health Service (NHS) of the UK, which offers the optimal infrastructure for the commercialization of medicines, plays a significant role in the larger pharmaceutical supply chain. The NHS makes a substantial contribution to UK pharma's strong worldwide competitiveness through collaborating with pharmaceutical firms. Additionally, it is vital in assisting clinical trials. For instance, hospitals in Birmingham are home to several of the top clinical research organizations in the UK and have aided in the development of innovative drugs.

PHARMACEUTICAL MARKET IN LONDON

Some of the most important biomedical discoveries in recent years, like the invention of in vitro fertilization (IVF) in the 1970s, have their roots in London. As a preventative measure against carcinogenic HPV strains, young girls were given one of the first routine universal anticancer vaccines in 2008 in the UK.

Five new AI Medical Centers are scheduled to debut in NHS hospitals in the UK over the course of the next year, demonstrating the London's growing capabilities in fields like artificial intelligence (AI) and digital health. These who use AI to improve disease diagnosis are supported by £50 million in government funding.

Past Conference Glimpses

Organizing Committee

Dr. Gary Heng liang

Fu Jen Catholic University Hospital

Taipei City, Taiwan

Dr Alan Goldhamer

Founder

TrueNorth Health Center

Burlingame, USA

Dr Ignacio Quiles Lara

Board of Directors

WBY Ventures

Florida, USA

Dr Wieslaw Swietnicki

IITD PAN

Warsaw, Poland

Dr. Joseph P. Fuhr, Jr.

Emeritus Professor, Pharmacoeconomics

University of Sciences

Phoenix, USA

Jorge González Borroto

Doctor, Pharmacovigilance

Ferrer Internacional

Barcelona, Spain

Dr Victor S. Dorodny

Founder and Chief Scientist, Naturopathy and traditional Medical Science

Naturopathic Evidence-based Wellness (NEW™) Institute

California, USA

Dr. Niranjan Koirala PhD.

Scientist, Biotechnology

University of Macau, Macau SAR

Beijing, China

To Collaborate Scientific Professionals around the World

Conference Date	March 27-28, 2023
Speaker Oppurtunity
Poster Oppurtunity	Available
e-Poster Oppurtunity	Available

Venue

Hospitality

The Pharmaceutical Science 2023 Conference will be held in London, United Kingdom.

The hotel personnel are not in charge of any specific information regarding the conference; they will only give generic information about the hotel and guest rooms.

Hotels close to Heathrow Airport are recommended if you plan to make hotel reservations on your own.

Venue: Hyatt Place London Heathrow Airport

Address: The Grove, Bath Rd, Harmondsworth, West Drayton UB7 0DG, United Kingdom

Join The Discussion

Similar Events
View All

Related Conferences

3rd International Conference on Pharmaceutics & Advanced Drug Delivery Systems

4th International Conference on Pharmaceutics & Advanced Drug Delivery Systems

5th International Conference on Pharmaceutics & Advanced Drug Delivery Systems

6th International Conference on Pharmaceutics & Advanced Drug Delivery Systems

National Registration

Quick Links

Contact Desk

Program Enquiries

Luna Grace

pharmaceuticalsciences@alliedgathering.org

+44 1324 238001

Sponsors/Exhibitors/Advertising

Madeline Leslie

pharmaceuticalsciences@alliedgathering.org

+44 1324 238001

General Queries

Alberto Kent

pharmaceuticalsciences@alliedgathering.org

+44 20 3769 1755

Previous Conferences

Conference Highlights

Pharmacogenomics

Neuropharmacology

Pharmacology

Pharmaceutical Marketing, Big Data, and Analytics

Digital Pharma & Multichannel Marketing

Pharmaceutical Microbiology and Biotechnology

Pharmaceutical Chemistry and Medicinal Chemistry

Biopharmaceutical

Pharmaceutical Nanotechnology

Pharmacovigilance and Drug Safety

Drug Discovery and Development

Clinical Trials and Drug Regulatory Affairs

Challenges in Drug Delivery

Advances in Drug Delivery

Nanotechnology and Drug carrier systems

Novel Drug Delivery Systems

Alternative Drug Delivery System

Peptides and Protein Drug delivery

Nutraceuticals

Analytical and Bioanalytical Techniques

Cosmeceuticals

General Practice and Emergency Care

Testimonials

Dear Luna, I really appreciated participating in the Pharmaceutical Sciences 2021 International Podcast. Thank you for this opportunity. Best regards, Andrea

Andrea Calcaterra

Dear Luna, It was really a pleasure to be part of such a wonderful event. Regards Atul

Atul Sharma

Thanks again Luna for reaching out to me to be involved in the Webinar. I enjoyed the presentations.

Chrishan Samuel

Dear Luna, Thanks a lot for your email and your precious support during the conference preparation and in the final steps. It has been a wonderful experience.

Fedora Grande

Dear Luna, Thank you so much for your email and feedback; I really appreciated it. The conference was excellent according to the one-day presentations, congratulations to all of you as organizers.

Flavia Zacconi

Dear Luna, I enjoyed very much the meeting and I thank the organizing committee for the invitation! Best regards, John Matsoukas

John Matsoukas

Greetings Luna Thanks a lot for giving me the opportunity to be one of the speakers in your respectable conference. I appreciate this, and honored to be involved in your upcoming organized events. Best regards.

Mohamed Nabil

I would like to thank you to give this chance to be a speaker with these big names.

MunIirah Abdullah Almessere

It is my pleasure to share the view on 6th edition of the Pharmaceutical Sciences International, was very nice and high informative with various Scientist presentations. It was a wonderful experience; very valuable information's. I appreciate the organizer and all presenters for organizing successful event.

Sivakumar

Dear Dr. Luna, It was a highly memorable moment for me as well. I could listen to the highly impactful research excerpts from learned researchers in all various fields of research. In fact, I would like to congratulate you also for selecting a theme which included experts from all the fields including human clinical, plant and animal sciences which otherwise many times becomes difficult to maintain a balance. Thank you so much for asking me to moderate the session. The interaction was very fruitful and informative. In future, as well I would love to render my services as much as I can. It was a pleasant experience interacting with you. Please never hesitate contacting me any time in future. Best regards, Sudarshan